Skip to content
HowShorted

AMAG PHARMACEUTICALS, INC. short interest in 2020

In 2020, AMAG PHARMACEUTICALS, INC.'s disclosed short interest ran from 43.18% of shares outstanding on 15 Jan 2020 to 10.82% on 13 Nov 2020, a change of -32.36 percentage points. The year's high was 43.18% on 15 Jan 2020 and its low 10.82% on 13 Nov 2020, averaging 32.58% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.72 days on 31 Aug 2020. Full history: AMAG PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020

Aggregate net short position time series for AMAG PHARMACEUTICALS, INC. in 2020

2020 in figures

Start of year
43.18% (15 Jan 2020)
End of year
10.82% (13 Nov 2020)
Change
-32.36 pp
High
43.18% (15 Jan 2020)
Low
10.82% (13 Nov 2020)
Average
32.58%
Highest days to cover
36.72 (31 Aug 2020)
SEC filings marked
8

Every report in 2020

AMAG PHARMACEUTICALS, INC. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202043.18%17.41results (8-K)
31 Jan 202040.65%9.69
14 Feb 202038.07%31.66
28 Feb 202037.17%18.36
13 Mar 202035.28%15.22results (8-K), 10-K filed
31 Mar 202034.65%18.03
15 Apr 202035.25%26.28
30 Apr 202035.82%26.53
15 May 202036.54%19.7810-Q filed, results (8-K)
29 May 202036.05%29.80
15 Jun 202036.44%29.32
30 Jun 202035.95%17.06
15 Jul 202034.90%34.15
31 Jul 202032.77%23.17
14 Aug 202031.55%24.84results (8-K)
31 Aug 202030.94%36.7210-Q filed
15 Sep 202029.47%24.36
30 Sep 202029.41%25.47
15 Oct 202020.96%1.29
30 Oct 202018.24%6.27
13 Nov 202010.82%2.5510-Q filed

See also: AMAG PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.